Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial.

Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial. Pol Arch Med Wewn. 2007 Sep; 117(9):389-90.

View in: PubMed

subject areas

Antihypertensive Agents
Blood Pressure
Diabetes Mellitus, Type 2
Drug Therapy, Combination
Humans
Indapamide
Perindopril
Randomized Controlled Trials as Topic
Risk Factors
Treatment Outcome
Vascular Diseases

authors with profiles

George Bakris